MDT Stock Recent News
MDT LATEST HEADLINES
Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.
Medtronic MDT (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and adjusted earnings of $1.30 per share compared to the consensus estimates of $7.9 billion and $1.26, respectively.
Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology firm posted better-than-expected results and raised its guidance on increased demand for its heart and diabetes devices.
In the bustling realm of forward-looking investments, robotics stocks stand out for their tremendous potential and relevance. These dynamic assets offer around-the-clock productivity, virtually uninterrupted by the mundane constraints of human labor.
In the closing of the recent trading day, Medtronic (MDT) stood at $86.18, denoting a -1.12% change from the preceding trading day.
Medical device maker Medtronic should benefit from a return to normality in the healthcare industry. United Parcel Service ought to experience better growth as macroeconomic conditions improve.
The top tech stocks are always a point of contention among investors. Some prefer sticking with reliable companies like the Magnificent 7, while others decry the same for being grossly overvalued.
Medtronic PLC's stock MDT rose 0.8% premarket Tuesday, after the medical device maker posted better-than-expected earnings for its fiscal second quarter and raised guidance. Dublin-based Medtronic posted net income of $909 million, or 68 cents a share, for the quarter to Oct. 27, up from $435 million, or 32 cents a share, in the year-earlier period.
Medtronic on Tuesday raised its annual profit forecast for the second time this year, banking on higher demand for its medical devices as surgery volumes pick up pace.